# Black Diamond Therapeutics, Inc.: Form 8-K, filed May 16, 2023

- Company: [Black Diamond Therapeutics, Inc.](/companies/bdtx.md) (CIK 1701541)
- Form: 8-K
- Filed: 2023-05-16
- Accepted by EDGAR: May 16, 2023, 17:26 ET
- Period: 2023-05-16
- Accession: 0001104659-23-061486
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701541/000110465923061486/tm2315952d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701541/000110465923061486/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701541/000110465923061486/tm2315952d1_8k.htm

Filed May 16, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-061486. Last ingested by Listed: Nov 10, 2026, 16:37 ET. No prices; not investment advice.